646 related articles for article (PubMed ID: 19358302)
1. The cost of health care for children and adults with sickle cell disease.
Kauf TL; Coates TD; Huazhi L; Mody-Patel N; Hartzema AG
Am J Hematol; 2009 Jun; 84(6):323-7. PubMed ID: 19358302
[TBL] [Abstract][Full Text] [Related]
2. Sickle cell disease-related pediatric medical expenditures in the U.S.
Amendah DD; Mvundura M; Kavanagh PL; Sprinz PG; Grosse SD
Am J Prev Med; 2010 Apr; 38(4 Suppl):S550-6. PubMed ID: 20331957
[TBL] [Abstract][Full Text] [Related]
3. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.
Mvundura M; Amendah D; Kavanagh PL; Sprinz PG; Grosse SD
Pediatr Blood Cancer; 2009 Oct; 53(4):642-6. PubMed ID: 19492318
[TBL] [Abstract][Full Text] [Related]
4. Healthcare utilization and expenditures for low income children with sickle cell disease.
Raphael JL; Dietrich CL; Whitmire D; Mahoney DH; Mueller BU; Giardino AP
Pediatr Blood Cancer; 2009 Feb; 52(2):263-7. PubMed ID: 18837428
[TBL] [Abstract][Full Text] [Related]
5. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
Kourtis AP; Bansil P; Johnson C; Meikle SF; Posner SF; Jamieson DJ
Pediatr Infect Dis J; 2007 May; 26(5):406-10. PubMed ID: 17468650
[TBL] [Abstract][Full Text] [Related]
6. Cost and utilization analysis of a pediatric emergency department diversion project.
Wang C; Villar ME; Mulligan DA; Hansen T
Pediatrics; 2005 Nov; 116(5):1075-9. PubMed ID: 16263992
[TBL] [Abstract][Full Text] [Related]
7. Cost of hospitalizations associated with sickle cell disease in the United States.
Davis H; Moore RM; Gergen PJ
Public Health Rep; 1997; 112(1):40-3. PubMed ID: 9018287
[TBL] [Abstract][Full Text] [Related]
8. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
[TBL] [Abstract][Full Text] [Related]
9. Caregiving time in sickle cell disease: psychological effects in maternal caregivers.
Moskowitz JT; Butensky E; Harmatz P; Vichinsky E; Heyman MB; Acree M; Wrubel J; Wilson L; Folkman S
Pediatr Blood Cancer; 2007 Jan; 48(1):64-71. PubMed ID: 16622841
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
Stallworth JR; Jerrell JM; Tripathi A
Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
Tripathi A; Jerrell JM; Stallworth JR
Ann Hematol; 2011 Feb; 90(2):145-50. PubMed ID: 20714723
[TBL] [Abstract][Full Text] [Related]
12. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.
Blinder MA; Duh MS; Sasane M; Trahey A; Paley C; Vekeman F
J Emerg Med; 2015 Oct; 49(4):513-522.e1. PubMed ID: 25910824
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.
Candrilli SD; O'Brien SH; Ware RE; Nahata MC; Seiber EE; Balkrishnan R
Am J Hematol; 2011 Mar; 86(3):273-7. PubMed ID: 21328441
[TBL] [Abstract][Full Text] [Related]
14. High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease.
Raphael JL; Mei M; Mueller BU; Giordano T
Pediatr Blood Cancer; 2012 Apr; 58(4):584-90. PubMed ID: 21584938
[TBL] [Abstract][Full Text] [Related]
15. Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease.
Shankar SM; Arbogast PG; Mitchel E; Ding H; Wang WC; Griffin MR
Pediatr Blood Cancer; 2008 Jan; 50(1):66-71. PubMed ID: 16998856
[TBL] [Abstract][Full Text] [Related]
16. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
17. Vesicoureteral reflux and ureteroceles.
Pohl HG; Joyce GF; Wise M; Cilento BG
J Urol; 2007 May; 177(5):1659-66. PubMed ID: 17437779
[TBL] [Abstract][Full Text] [Related]
18. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.
Lanzkron S; Haywood C; Segal JB; Dover GJ
Am J Hematol; 2006 Dec; 81(12):927-32. PubMed ID: 16924648
[TBL] [Abstract][Full Text] [Related]
19. Impact of environmental tobacco smoke on children with sickle cell disease.
West DC; Romano PS; Azari R; Rudominer A; Holman M; Sandhu S
Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1197-201. PubMed ID: 14662575
[TBL] [Abstract][Full Text] [Related]
20. Incidence and costs of injuries in The Netherlands.
Meerding WJ; Mulder S; van Beeck EF
Eur J Public Health; 2006 Jun; 16(3):272-8. PubMed ID: 16476683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
